Filep Janos G
University of Montréal, Maisonneuve-Rosemont Hospital Research Centre, 5415 Boulevard de l'Assomption, Montréal, QC H1T 2M4, Canada.
IDrugs. 2010 Feb;13(2):73-5.
The BIT Life Sciences' Third Annual World Congress of Gene, held in Sanshui, China, included topics covering new developments in the field of gene-based therapeutic approaches and target identification. This conference report highlights selected presentations on aspirin-triggered lipoxins for inflammation, hepatocyte nuclear factor HNF4alpha as a target for intestinal inflammation, P2Y nucleotide receptor antagonism for inflammatory diseases, antioxidant approaches for hearing loss prevention, targeting protein kinase CK2 in neuronal injury, the role of AATF (apoptosis antagonizing transcription factor)-mediated neuroprotection in Alzheimer's disease, and lessons from bioactive proteins from plants.
比特生命科学公司第三届年度基因世界大会在中国三水举行，会议主题涵盖基于基因的治疗方法和靶点识别领域的新进展。本会议报告重点介绍了以下精选演讲：阿司匹林引发的脂氧素用于炎症治疗、肝细胞核因子HNF4α作为肠道炎症的靶点、P2Y核苷酸受体拮抗剂用于炎症性疾病、预防听力损失的抗氧化方法、针对神经元损伤靶向蛋白激酶CK2、AATF（凋亡拮抗转录因子）介导的神经保护在阿尔茨海默病中的作用，以及来自植物的生物活性蛋白的经验教训。
